49 results
8-K
ALGS
Aligos Therapeutics, Inc.
5 Sep 24
Other Events
4:06pm
”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company has regained compliance
PRE 14A
ALGS
Aligos Therapeutics, Inc.
16 Apr 24
Preliminary proxy
5:27pm
with listing requirements. The Nasdaq Listing Qualifications Department notified us on September 5, 2023 that the bid price of our common stock had closed
8-K
EX-4.1
sn9e2hhq038gi4
25 Oct 23
Entry into a Material Definitive Agreement
5:05pm
8-K
EX-4.2
s5nhfm vre5asp8rbm
25 Oct 23
Entry into a Material Definitive Agreement
5:05pm
8-K
EX-10.1
h4tewh8wca 03pc
25 Oct 23
Entry into a Material Definitive Agreement
5:05pm
8-K
zdlkn6g
7 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:01pm